FDA Delays Impacting Inflammatory Skin Disease Community

Mark Lebwohl, MD, explains the recent delay in approval of JAK inhibitors by the FDA, how it is affecting the inflammatory skin disease community, and if physicians should be concerned.

Related Videos

Related Content

New Guidelines to Prevent Food Allergies in Pediatric Atopic Dermatitis Patients

March 21st 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

POLL: What is Your Current Approach to Peanut Allergies in Your Atopic Dermatitis Patients?

March 21st 2023

The Cutaneous Connection: JAK Inhibitor Safety for Treating AD

December 14th 2022

Raj Chovatiya, MD, PhD, Discusses All Things Inflammatory Diseases at AAD 2023

March 20th 2023

Ruxolitinib Cream Maintains Disease and Symptom Control in Adults and Adolescents With AD

March 19th 2023

New Guidelines to Prevent Food Allergies in Pediatric Atopic Dermatitis Patients

March 21st 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

POLL: What is Your Current Approach to Peanut Allergies in Your Atopic Dermatitis Patients?

March 21st 2023

The Cutaneous Connection: JAK Inhibitor Safety for Treating AD

December 14th 2022

Raj Chovatiya, MD, PhD, Discusses All Things Inflammatory Diseases at AAD 2023

March 20th 2023

Ruxolitinib Cream Maintains Disease and Symptom Control in Adults and Adolescents With AD

March 19th 2023

New Guidelines to Prevent Food Allergies in Pediatric Atopic Dermatitis Patients

March 21st 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

POLL: What is Your Current Approach to Peanut Allergies in Your Atopic Dermatitis Patients?

March 21st 2023

The Cutaneous Connection: JAK Inhibitor Safety for Treating AD

December 14th 2022

Raj Chovatiya, MD, PhD, Discusses All Things Inflammatory Diseases at AAD 2023

March 20th 2023

Ruxolitinib Cream Maintains Disease and Symptom Control in Adults and Adolescents With AD

March 19th 2023

Related Content

New Guidelines to Prevent Food Allergies in Pediatric Atopic Dermatitis Patients

Article

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

Podcast

POLL: What is Your Current Approach to Peanut Allergies in Your Atopic Dermatitis Patients?

Article

The Cutaneous Connection: JAK Inhibitor Safety for Treating AD

Podcast

Raj Chovatiya, MD, PhD, Discusses All Things Inflammatory Diseases at AAD 2023

Article

Ruxolitinib Cream Maintains Disease and Symptom Control in Adults and Adolescents With AD

Article